Open Accessibility Menu

Clinical Trial Information

Diabetic Foot Ulcer Trial with Topical Medication (non-infected)
  • Category: Diabetic Foot
  • Starts: May 1, 2023

Description of Trial:

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Phase-III Study to Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Protocol Number: ON101CLCT04

Synopsis: Diabetic foot ulcers commonly develop quickly and can be difficult to heal. These ulcers can and often lead to more serious complications, such as infection in 60% of the cases. However the best time to treat these early wounds with the greatest potential towards healing is before a deeper infection, such as osteomyelitis or bone infection occurs. This study involves the use of a new and exciting topically applied medication which may allow for faster healing and reduced risk of complications. All study related procedures and treatment is at no cost to the patient. Financial compensation for time and travel is offered. Medical/health insurance is not required.

Status: Enrolling Patients in April